Back to FAQ Regarding COVID-19 Vaccines
Back to Coronavirus Research
Back to Coronavirus Research
Back to iPS Cell Biobank
jp2logo.jpg

  • Home

  • About

    • Annual Reports
    • Financial Reports
    • Our Mission
    • Board Members and Officers
    • Advisor Committees
    • Endorsements
    • Institute Differs From Other Foundations
    • FAQ
    • Survey Question
    • Careers
    • Disclosure Forms

  • News

  • Education

    • General Stem Cell Education
    • Embryonic Stem Cells
    • The Promise of Stem Cells
    • Cloning
    • The Promise of SCNT
    • Links
    • Science Corner

  • Research

    • Research Overview
    • Institute Goals
    • Non-Profit Biotech Model
    • Gene Therapy vs. Cell Therapy
    • Specific Research Programs
    • iPS Cell Biobank
    • Secular Biotechnologies That Threaten...
    • Personalized Medicine in Oncology
    • Coronavirus Research
    • Research Milestones

  • Research Ethics

    • Human Research Ethics Information
    • National Research Act
    • Historical Examples
    • Nuremberg Code
    • Declaration of Helsinki
    • History of Human Embryonic Research
    • NIH Revitalization Act

  • Ways to Help

    • Donate Now
    • Planned Gift Giving
    • Employee Matching Gift Programs
    • Hold Your Own Fundraising Event
    • Capital Campaign for Cell Therapies
    • Campaign for a COVID-19 Vaccine
    • You Can Help
    • Downloadable Materials
    • Knights of Columbus
    • Real Estate for Life
    • Art for Life

  • Contact Us

  • Shop

    • T-Shirts/Sweatshirts

  • More

    Use tab to navigate through the menu items.

    Gaucher Disease, Type I

    Back to iPS Cell Biobank

    © 2022 John Paul II Medical Research Institute.

    ​

    Address:

    John Paul II Medical Research Institute
    2500 Crosspark Rd

    Suite W230
    Coralville, IA 52241

    ​

    Phone: (319) 688-7367

    Fax: (319) 887-2870

    • gab-logo
    • 320px-Rumble_logo_edited
    • Twitter
    • Facebook
    • YouTube